RAHIKA 150MG TABLET

Form: Tablets

Pack Size: 60 TABLETS (5X12)

Marketed by: NOVARTIS HEALTHCARE PVT LTD (ONCOLOGY DIV)

MRP: ₹74695.00

NOVARTIS HEALTHCARE PVT LTD (ONCOLOGY DIV): Rahika 150MG Tablet, 60 tablets (5x12), salt capmatinib 150mg. Its MRP stays at Rs 74,695 in NPPA's 09-11-2026 anti-cancer trade-margin revision; trade rate Rs 56,910.48. Group: MET inhibitor (targeted therapy). No other manufacturer of this salt and strength is listed here yet. Handling/counselling: patient should avoid strong sun exposure. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.